Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAdvanced Biomed Inc. Common Stock Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/19/2025 | Q1 2026 | N/A | -$0.00 | N/A | N/A | $0 |
| 10/08/2025 | Q4 2025 | N/A | -$0.00 | N/A | N/A | $17.20 K |
| 05/15/2025 | Q3 2025 | N/A | -$0.07 | N/A | N/A | $0 |
| 04/15/2025 | Q2 2025 | N/A | -$0.05 | N/A | N/A | $0 |
| 09/30/2024 | Q1 2025 | N/A | -$0.01 | N/A | N/A | $0 |
| 06/30/2024 | Q4 2024 | N/A | -$0.05 | N/A | N/A | $0 |
| 03/31/2024 | Q3 2024 | N/A | -$0.05 | N/A | N/A | $0 |
| 12/31/2023 | Q2 2024 | N/A | -$0.01 | N/A | N/A | $0 |
| 09/30/2023 | Q1 2024 | N/A | -$0.04 | N/A | N/A | $0 |
| 06/30/2023 | Q4 2023 | N/A | -$0.08 | N/A | N/A | $0 |
| 03/31/2023 | Q3 2023 | N/A | -$0.03 | N/A | N/A | $0 |
| 12/31/2022 | Q2 2023 | N/A | -$0.02 | N/A | N/A | $0 |
| 09/30/2022 | Q1 2023 | N/A | -$0.06 | N/A | N/A | $0 |
| 06/30/2022 | Q4 2022 | N/A | -$0.13 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Advanced Biomed Inc. Common Stock Earnings: FAQ's
Advanced Biomed Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 15th, 2025 based offlast year's report dates.
The conference call for Advanced Biomed Inc. Common Stock's latest earnings report can be listened to online.
The conference call transcript for Advanced Biomed Inc. Common Stock's latest earnings report can be read online.
Advanced Biomed Inc. Common Stock (:ADVB) has a recorded net income of $-101,524.Advanced Biomed Inc. Common Stock has generated $-0.0047 earnings per share over the last four quarters.
Advanced Biomed Inc. Common Stock (:ADVB) has a price-to-earnings ratio of -3.52 and price/earnings-to-growth ratio is -0.46.